Vaccines and the Microbiome

The bacteria that exist throughout the human body, known as the microbiome, play a variety of roles in the development of the immune system. This is particularly true during infancy when the microbiome and the immune response are developing in tandem. Most vaccines are administered in early childhood to prevent outbreaks of devastating childhood diseases. A higher relative abundance of the phylum Actinobacteria (oral and parenteral vaccines) and Firmicutes (oral vaccines) was associated with both higher humoral and higher cellular vaccine responses, while a higher relative abundance of the phylum Proteobacteria (oral and parenteral vaccines) and Bacteroidetes (oral vaccines) was associated with lower responses. Subjects whose intestinal microbiota is dominated by Bifidobacterium demonstrated a broader level of adaptive immune response to vaccinations. On the other hand, infants with higher ratios of Enterobacteriales, Pseudomonadales, and Clostridiales in their intestinal microbiota exhibited lower immune response to vaccination.

    Related Conference of Vaccines and the Microbiome

    March 17-18, 2025

    54th World Congress on Microbiology

    Berlin, Germany
    July 28-29, 2025

    17th International Virology Summit

    Paris, France
    August 25-26, 2025

    6th International Conference on Molecular Microbiology

    Singapore City, Singapore
    September 22-23, 2025

    13th World Congress and Expo on Applied Microbiology

    Dubai, UAE

    Vaccines and the Microbiome Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in